The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Christianson Mark since 2020.
This trader's CIK number is 1709738.
At the time of last reporting, Christianson Mark was the Business Development Director of Neuroone Medical Technologies Corp. (stock ticker symbol NMTC).
Also see all insider trading activities at Neuroone Medical Technologies Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NMTC | 0 | $0 | 30,000 | $18,702 | 0 | $0 |
| 2024 | NMTC | 0 | $0 | 27,989 | $24,569 | 0 | $0 |
| 2023 | NMTC | 0 | $0 | 76,500 | $111,608 | 0 | $0 |
| 2021 | NMTC | 0 | $0 | 11,900 | $79,975 | 0 | $0 |
| 2020 | NMTC | 0 | $0 | 334,000 | $200,400 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-04 | NMTC | Sale | 10,000 | .58 | 5,800 |
| 2025-05-21 | NMTC | Sale | 14 | .65 | 9 |
| 2025-05-22 | NMTC | Sale | 8,967 | .62 | 5,586 |
| 2025-05-19 | NMTC | Sale | 8,006 | .67 | 5,331 |
| 2025-05-20 | NMTC | Sale | 3,013 | .66 | 1,976 |
| 2024-06-06 | NMTC | Sale | 2,189 | .88 | 1,917 |
| 2024-06-05 | NMTC | Sale | 25,800 | .88 | 22,652 |
| 2023-12-26 | NMTC | Sale | 6,848 | 1.35 | 9,272 |
| 2023-12-27 | NMTC | Sale | 31,445 | 1.46 | 45,846 |
| 2023-12-21 | NMTC | Sale | 9,907 | 1.40 | 13,869 |
| 2023-12-22 | NMTC | Sale | 1,800 | 1.40 | 2,520 |
| 2023-03-21 | NMTC | Sale | 2,122 | 1.60 | 3,405 |
| 2023-03-22 | NMTC | Sale | 11,667 | 1.51 | 17,605 |
| 2023-03-23 | NMTC | Sale | 12,711 | 1.50 | 19,091 |
| 2021-06-23 | NMTC | Sale | 11,300 | 6.74 | 76,195 |
| 2021-06-24 | NMTC | Sale | 600 | 6.30 | 3,780 |
| 2020-06-12 | NMTC | Sale | 334,000 | .60 | 200,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Christianson Mark (Business Development Director of Neuroone Medical Technologies Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.